Studies have shown that GPER mediates nongenomic signal transduction of estrogen in a variety of estrogen-sensitive cancer cells by activating the nongenomic EGFR-dependent signaling pathway formed by PI3K/Akt [20, 21]. This evidence concerns the gene EGFR and cancer.